Biosimilar Contract Manufacturing Market Analysis: Competitive Landscape and Emerging Opportunities
The Biosimilar Contract Manufacturing Market is developing across major global healthcare regions as pharmaceutical companies seek efficient and scalable solutions for biosimilar production. The market is forecast to reach USD 51.9 billion by 2035, expanding at a CAGR of 18.9% during 2025–2035. North America currently represents the leading regional market, accounting for more than...
0 Comments 0 Shares 84 Views 0 Reviews